Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2012
06/21/2012WO2012079435A1 Scorpion active peptides and preparation methods and applications thereof
06/21/2012WO2012079370A1 Verticillium dahliae protein elicitor gene, protein sequence and use thereof
06/21/2012WO2012079222A1 Mannanase, coding gene and production thereof
06/21/2012WO2012079125A1 Designed biosurfactants, their manufacture, purification and use
06/21/2012WO2012058220A3 Anti-sod1 antibodies and uses thereof
06/21/2012WO2012057508A3 Method for controlling the chaperone activity of peroxiredoxins using irradiation
06/21/2012WO2012054907A3 Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
06/21/2012WO2012054509A3 Discovery of regulatory t cells programmed to suppress an immune response
06/21/2012WO2012049317A3 Cytomegalovirus gb antigen
06/21/2012WO2012048115A3 Polypeptides and their use in treating and limiting respiratory syncytial virus infection
06/21/2012WO2012040323A3 Multimeric il-15 soluble fusion molecules and methods of making and using same
06/21/2012WO2012027376A3 Method for expansion of stem cells and the use of such cells
06/21/2012WO2012021512A3 Erythrocyte-binding therapeutics
06/21/2012WO2012013191A3 Recombinant proteins as vaccines for protection against disease induced by infection with mink astrovirus
06/21/2012US20120159673 Gene for increasing plant weight and method for using the same
06/21/2012US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
06/21/2012US20120159671 Seeds
06/21/2012US20120159661 T-Bet Compositions and Methods of Use Thereof
06/21/2012US20120157668 Methods for removal of microcystins and isolation of phycocyanin from cyanobacteria
06/21/2012US20120157660 Novel peptides that bind to the erythropoietin receptor
06/21/2012US20120157659 Affinity peptides and method for purification of recombinant proteins
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production
06/21/2012US20120157509 GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA
06/21/2012US20120157391 Proteoglycan-containing material
06/21/2012US20120157389 Peptides for treating cancer
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157380 Pegylated human apoa-1 and process for production thereof
06/21/2012US20120157379 Gastric Inhibitory Peptide Variants and Their Uses
06/21/2012US20120157376 Pharmacologically active antiviral peptides and methods of their use
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120156803 Biologically-active radiolabeled cry1fa and receptor binding assay methods
06/21/2012US20120156770 Human androgen receptor alternative splice variants
06/21/2012US20120156757 Purification of immunogens using a non-polysaccharide matrix
06/21/2012US20120156751 Preparation and isolation of 5' capped mrna
06/21/2012US20120156722 Tumor Suppressor Gene
06/21/2012US20120156719 Method for universal enzymatic production of bioactive peptides
06/21/2012US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress
06/21/2012US20120156694 Proteins used for the diagnosis of lyme borreliosis
06/21/2012US20120156692 Method for selecting marker for diagnosis of nutritional status of plant, method for diagnosing nutritional status of plant, and method for determining growth status
06/21/2012US20120156276 Connective tissue stimulating peptides
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156235 Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156211 Porphyromonas gingivalis polypeptides
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156175 Composition for inducing migration of neural stem cells containing periostin as effective ingredient
06/21/2012US20120156173 Fusarium and other pathogenic fungi and mycotoxin biocontrol
06/21/2012US20120156167 Enhancin gene bel1 from bacillus thuringiensis and its use in biological insecticide
06/21/2012US20120156140 Fluorescent compounds
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012US20120155620 Personal-Call and Feature Control System and Method for Controlling Telephones, Providing Extended Features for Such Telephones and Routing of Media-Rich Calls
06/21/2012US20120153221 Real Time Monitoring and Control of Protein Production Processes Using Impedance Spectroscopy
06/21/2012CA2828794A1 Cell culture medium
06/21/2012CA2826252A1 Recombinant laminin-521
06/21/2012CA2821945A1 Aqueous factor viii solution
06/21/2012CA2821908A1 Novel biomarker and uses thereof in diagnosis, treatment of autism
06/21/2012CA2821711A1 Eluate collection using conductivity gradient
06/21/2012CA2821582A1 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
06/21/2012CA2821519A1 Combined use of vip3ab and cry1ab for management of resistant insects
06/21/2012CA2821255A1 Biologically-active radiolabeled cry1fa and receptor binding assay methods
06/21/2012CA2816246A1 Malodour standards and inhibitors
06/21/2012CA2815286A1 Cry1i proteins and genes for insect control
06/21/2012CA2814953A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465927A1 Influenza hemagglutinin and neuraminidase variants
06/20/2012EP2465869A1 Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family
06/20/2012EP2465868A1 Improvement of lipid production
06/20/2012EP2465867A2 Peptide vaccines for cancers expressing tumor-associated antigens
06/20/2012EP2465866A2 Peptide vaccines for cancers expressing tumor-associated antigens
06/20/2012EP2465865A2 Peptide vaccines for cancers expressing tumor-associated antigens
06/20/2012EP2465864A2 Peptide vaccines for cancers expressing tumor-associated antigens
06/20/2012EP2465533A1 Methods and compositions comprising supramolecular constructs
06/20/2012EP2465531A1 Apoptosis-inducing polypeptides
06/20/2012EP2465530A1 Multivalent entrain-and-amplify immunotherapeutics for carcinoma
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465523A1 FVIII-derived peptides and their use in tolerising haemophiliacs
06/20/2012EP2465522A1 Chemerin-15h and its use for treatment of inflammation and endotoxic shock
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465511A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465510A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2464733A1 Stress tolerant plants
06/20/2012EP2464663A2 Engineered proteins including mutant fibronectin domains
06/20/2012EP2464662A1 Complexing system
06/20/2012EP2464661A2 Methods of modulating immune function
06/20/2012EP2464660A2 Methods of treating cancer using glucagon-like hormone retargeted endopeptidases
06/20/2012EP2464659A1 Methods of treating cancer using opioid retargeted endpeptidases
06/20/2012EP2464658A1 Detoxified escherichia coli immunogens
06/20/2012EP2464657A1 Novel screening strategies for the identification of binders
06/20/2012EP2464655A1 Chromatographic processes and purified compounds thereof
06/20/2012EP2464446A1 Cross-flow membrane filtration-based process for protein recovery
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 2916